Subscribe

State Street SPDR S&P Biotech ETF (XBI)

USD155.34 -3.69 (-2.32%)
AMEX USD US Equity
NAV USD 159.03 -2.32% vs NAV as of 2026-07-13
AUM USD 10.82B
TER 0.35%
Yield (TTM) 0.37%
Distribution Distributing · Semi-Annual
52-week range 85.16 – 164.28
Holdings 160
Issuer SPDR

About this ETF

SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.

ISIN US78464A8707
Issuer SPDR
Domicile US
Inception 2006-01-31
Asset class Equity

Price